Citrulline malate supplementation does not improve German Volume Training performance or reduce muscle soreness in moderately trained males and females

Journal of the International Society of Sports Nutrition
Q1
Aug 2018
Citations:41
Influential Citations:7
Interventional (Human) Studies
93
S2 IconPDF Icon

Enhanced Details

Methods
Design: randomized, double-blind, placebo-controlled cross-over trial. Participants: healthy recreationally active men and women; fifteen completed (11 male, 4 female); mean age 23.7 ± 2.4 years; regular resistance training ≥2 times/week for ≥6 months; non-smokers; no injuries or chronic conditions; maintained usual diet and avoided new supplements.
Intervention
8 g Citrulline Malate per dose (4.21 g citrulline + 3.79 g malate; ratio 1.11:1), dissolved in 70 ml fruit cordial and 150 ml water, consumed within 5 minutes, 60 minutes before exercise; acute per-session dosing (two sessions).
Results
Acute 8 g CM dose did not significantly improve anaerobic performance in recreationally active adults performing German Volume Training. Across 10 sets, total repetitions: placebo 94.0 ± 7.9 vs CM 90.9 ± 13.9 (P = 0.33). No significant differences in peak force after GVT for isometric, concentric, or eccentric contractions (P = 0.60, 0.38, 0.65). Blood lactate responses were similar (pre: 1.45 ± 0.54 vs 1.69 ± 1.07 mmol/L; post: 4.16 ± 1.34 vs 4.31 ± 1.31 mmol/L; delta: 2.87 ± 1.53 vs 2.51 ± 1.25; P > 0.48). Total muscle soreness over 72 h was higher with CM than placebo (P < 0.01). Conclusion: Acute CM at 8 g does not enhance anaerobic performance and may increase soreness; caution in recommending CM; product composition may differ from manufacturer claims; further trials needed.
Limitations
Small sample size (n=15 completed); some measurements incomplete due to technical issues (Fmax follow-up in 10 participants); mixed-sex sample with varying training histories; menstrual cycle not controlled; testing not fasting; dietary/supplement controls limited; potential under-dosing due to actual citrulline:malate ratio differing from label; single acute-dose design; isokinetic single-joint protocol may limit generalizability to real-world multi-joint exercises.

Abstract

No abstract available